NASDAQ:CAPR - Capricor Therapeutics News Headlines

$5.64
+0.39 (+7.43 %)
(As of 07/19/2019 04:00 PM ET)
Today's Range
$5.25
Now: $5.64
$6.04
50-Day Range
$0.2950
MA: $3.34
$7.83
52-Week Range
$2.53
Now: $5.64
$13.60
Volume505,350 shs
Average Volume2.22 million shs
Market Capitalization$19.57 million
P/E RatioN/A
Dividend YieldN/A
Beta1.7

Headlines

Capricor Therapeutics (NASDAQ CAPR) News Headlines

Source:
DateHeadline
Capricor Therapeutics: Caution Is AdvisedCapricor Therapeutics: Caution Is Advised
seekingalpha.com - July 17 at 6:43 PM
Capricor Therapeutics and Parents Project Muscular Dystrophy to Host Webinar to Discuss Interim Analysis of the HOPE-2 Clinical Trial to Treat Patients with Duchenne Muscular DystrophyCapricor Therapeutics and Parents Project Muscular Dystrophy to Host Webinar to Discuss Interim Analysis of the HOPE-2 Clinical Trial to Treat Patients with Duchenne Muscular Dystrophy
finance.yahoo.com - July 17 at 8:30 AM
Capicor Therapeutics stock rockets on heavy volume after positive MD trial resultsCapicor Therapeutics' stock rockets on heavy volume after positive MD trial results
www.marketwatch.com - July 15 at 6:58 PM
Why Is Capricor Moving?Why Is Capricor Moving?
www.benzinga.com - July 15 at 6:58 PM
Why Capricor May Be the Next Big Name in Duchenne Muscular DystrophyWhy Capricor May Be the Next Big Name in Duchenne Muscular Dystrophy
247wallst.com - July 15 at 6:58 PM
U.S. STOCKS ON THE MOVE-Callon Petroleum, Capricor Therapeutics, SymantecU.S. STOCKS ON THE MOVE-Callon Petroleum, Capricor Therapeutics, Symantec
www.nasdaq.com - July 15 at 6:58 PM
Capicor Therapeutics' stock rockets on heavy volume after positive MD trial resultsCapicor Therapeutics' stock rockets on heavy volume after positive MD trial results
finance.yahoo.com - July 15 at 6:58 PM
Capricor Therapeutics (NASDAQ:CAPR) Price Target Increased to $12.40 by Analysts at HC WainwrightCapricor Therapeutics (NASDAQ:CAPR) Price Target Increased to $12.40 by Analysts at HC Wainwright
www.americanbankingnews.com - July 15 at 2:19 PM
Capricor up 45% premarket on positive CAP-1002 dataCapricor up 45% premarket on positive CAP-1002 data
seekingalpha.com - July 15 at 8:27 AM
Capricor Therapeutics Announces Positive Results from its Interim Analysis in the HOPE-2 Trial to Treat Patients with Duchenne Muscular DystrophyCapricor Therapeutics Announces Positive Results from its Interim Analysis in the HOPE-2 Trial to Treat Patients with Duchenne Muscular Dystrophy
finance.yahoo.com - July 15 at 8:27 AM
Capricor Therapeutics Inc (NASDAQ:CAPR) Short Interest Down 32.2% in JuneCapricor Therapeutics Inc (NASDAQ:CAPR) Short Interest Down 32.2% in June
www.americanbankingnews.com - July 11 at 11:17 PM
Cell Therapy Market 2019-2025Cell Therapy Market 2019-2025
www.marketwatch.com - July 6 at 8:18 AM
What Kind Of Shareholders Own Capricor Therapeutics, Inc. (NASDAQ:CAPR)?What Kind Of Shareholders Own Capricor Therapeutics, Inc. (NASDAQ:CAPR)?
finance.yahoo.com - July 2 at 6:40 PM
Capricor Therapeutics Inc (NASDAQ:CAPR) Short Interest UpdateCapricor Therapeutics Inc (NASDAQ:CAPR) Short Interest Update
www.americanbankingnews.com - June 26 at 7:49 PM
Capricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q1 2019 Results - Earnings Call TranscriptCapricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 14 at 8:40 AM
Data readout from mid-stage study of Capricors CAP-1002 expected next quarter; shares up 5% after hoursData readout from mid-stage study of Capricor's CAP-1002 expected next quarter; shares up 5% after hours
seekingalpha.com - May 13 at 7:55 PM
Capricor Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate UpdateCapricor Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
www.globenewswire.com - May 13 at 7:55 PM
Capricor Therapeutics (CAPR) Reports Q1 Loss, Lags Revenue EstimatesCapricor Therapeutics (CAPR) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 13 at 7:55 PM
Capricor Therapeutics to Present First Quarter 2019 Financial Results and Recent Corporate Update on May 13Capricor Therapeutics to Present First Quarter 2019 Financial Results and Recent Corporate Update on May 13
www.globenewswire.com - May 6 at 7:40 PM
Capricor Therapeutics to Present First Quarter 2019 Financial Results and Recent Corporate Update on May 13Capricor Therapeutics to Present First Quarter 2019 Financial Results and Recent Corporate Update on May 13
finance.yahoo.com - May 6 at 7:40 PM
Will Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) Earnings Grow In The Years Ahead?Will Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) Earnings Grow In The Years Ahead?
finance.yahoo.com - April 5 at 7:49 PM
Capricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q4 2018 Results - Earnings Call TranscriptCapricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 29 at 8:27 AM
Capricor Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate UpdateCapricor Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - March 28 at 7:26 PM
Capricor: 4Q Earnings SnapshotCapricor: 4Q Earnings Snapshot
finance.yahoo.com - March 28 at 7:26 PM
Capricor Therapeutics to Present Fourth Quarter and Full Year 2018 Financial Results and Recent Corporate Update on March 28Capricor Therapeutics to Present Fourth Quarter and Full Year 2018 Financial Results and Recent Corporate Update on March 28
finance.yahoo.com - March 21 at 8:57 AM
BRIEF-Capricor Resumes Dosing Of Enrolled Patients In Hope-2 Clinical Trial For Duchenne Muscular DystrophyBRIEF-Capricor Resumes Dosing Of Enrolled Patients In Hope-2 Clinical Trial For Duchenne Muscular Dystrophy
www.msn.com - March 2 at 8:16 AM
Capricor Therapeutics, Inc. (NASDAQ:CAPR): Commentary On FundamentalsCapricor Therapeutics, Inc. (NASDAQ:CAPR): Commentary On Fundamentals
finance.yahoo.com - February 21 at 8:28 AM
Capricor Resumes Dosing of Enrolled Patients in HOPE-2 Clinical Trial for Duchenne Muscular DystrophyCapricor Resumes Dosing of Enrolled Patients in HOPE-2 Clinical Trial for Duchenne Muscular Dystrophy
finance.yahoo.com - February 6 at 8:24 AM
Neurology Publishes Study Reporting Significant Improvements in Duchenne Muscular Dystrophy Patients Treated with Capricor’s Novel Cell TherapyNeurology Publishes Study Reporting Significant Improvements in Duchenne Muscular Dystrophy Patients Treated with Capricor’s Novel Cell Therapy
finance.yahoo.com - January 24 at 8:16 AM
Capricor Therapeutics (CAPR) Reports Positive Outcomes from Comprehensive Multidisciplinary Meeting with FDA - StreetInsider.comCapricor Therapeutics (CAPR) Reports Positive Outcomes from Comprehensive Multidisciplinary Meeting with FDA - StreetInsider.com
www.streetinsider.com - January 22 at 8:17 AM
Capricor Announces Positive Outcomes from Comprehensive Multidisciplinary Meeting with FDACapricor Announces Positive Outcomes from Comprehensive Multidisciplinary Meeting with FDA
finance.yahoo.com - January 22 at 8:17 AM
Does Capricor Therapeutics, Inc.’s (NASDAQ:CAPR) CEO Pay Reflect Performance?Does Capricor Therapeutics, Inc.’s (NASDAQ:CAPR) CEO Pay Reflect Performance?
finance.yahoo.com - January 18 at 5:45 PM
Sarepta +2.5% on trial hold for competitor - Seeking AlphaSarepta +2.5% on trial hold for competitor - Seeking Alpha
seekingalpha.com - December 27 at 8:28 AM
BRIEF-Capricor Therapeutics Says It Has Put Its Hope-2 Clinical Trial On A Voluntary Dosing HoldBRIEF-Capricor Therapeutics Says It Has Put Its Hope-2 Clinical Trial On A Voluntary Dosing Hold
www.msn.com - December 26 at 8:22 AM
Capricor Therapeutics -2% on DMD trial haltCapricor Therapeutics -2% on DMD trial halt
seekingalpha.com - December 26 at 8:22 AM
U.S. drug developer Capricor places Duchenne drug trial on holdU.S. drug developer Capricor places Duchenne drug trial on hold
finance.yahoo.com - December 26 at 8:22 AM
Could The Capricor Therapeutics Inc (NASDAQ:CAPR) Ownership Structure Tell Us Something Useful?Could The Capricor Therapeutics Inc (NASDAQ:CAPR) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - December 4 at 5:39 PM
Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key PlayersExosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players
www.marketwatch.com - November 27 at 5:19 PM
Exosome Technologies Markets 2018-2024: Capricor...Exosome Technologies Markets 2018-2024: Capricor...
www.benzinga.com - November 23 at 8:27 AM
Global Exosome Technologies Market to 2024: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players - ResearchAndMarkets.comGlobal Exosome Technologies Market to 2024: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players - ResearchAndMarkets.com
www.businesswire.com - November 22 at 5:26 PM
Capricor Therapeutics (CAPR) Reports Q3 Loss, Lags Revenue EstimatesCapricor Therapeutics (CAPR) Reports Q3 Loss, Lags Revenue Estimates
www.zacks.com - November 13 at 5:12 PM
Capricor Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate UpdateCapricor Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - November 13 at 5:12 PM
Capricor: 3Q Earnings SnapshotCapricor: 3Q Earnings Snapshot
finance.yahoo.com - November 13 at 5:12 PM
Capricor Therapeutics (CAPR) to Meet with FDA under its RMAT Designation to Discuss HOPE-2 Clinical TrialCapricor Therapeutics (CAPR) to Meet with FDA under its RMAT Designation to Discuss HOPE-2 Clinical Trial
www.streetinsider.com - November 13 at 8:16 AM
Capricor to Meet with FDA under its RMAT Designation to Discuss HOPE-2 Clinical TrialCapricor to Meet with FDA under its RMAT Designation to Discuss HOPE-2 Clinical Trial
finance.yahoo.com - November 12 at 8:21 AM
Capricor Therapeutics to Present Corporate Overview and Poster at Action Duchenne International ConferenceCapricor Therapeutics to Present Corporate Overview and Poster at Action Duchenne International Conference
finance.yahoo.com - November 8 at 8:20 AM
Analysts Estimate Capricor Therapeutics (CAPR) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Capricor Therapeutics (CAPR) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - November 7 at 5:48 PM
Capricor Therapeutics to Present Third Quarter Financial Results and Corporate Update on November 13Capricor Therapeutics to Present Third Quarter Financial Results and Corporate Update on November 13
finance.yahoo.com - November 6 at 8:17 AM
Capricor Therapeutics to Provide Corporate Update at BIO-Europe Conference on Nov. 6Capricor Therapeutics to Provide Corporate Update at BIO-Europe Conference on Nov. 6
finance.yahoo.com - November 2 at 8:14 AM
Capricor Therapeutics to Participate in Upcoming ConferencesCapricor Therapeutics to Participate in Upcoming Conferences
globenewswire.com - October 22 at 8:14 AM
This page was last updated on 7/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel